Concepedia

Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study

Cristina Mosconi, Annagiulia Gramenzi, Salvatore Ascanio, Alberta Cappelli, Matteo Renzulli, Cinzia Pettinato, Giovanni Brandi, Fabio Monari, Alessandro Cucchetti, Franco Trevisani,

British Journal of Cancer · 2016 · 69 citations · 24 references

DOIFull text

Open access

Abstract

In unresectable ICC, (90)Y-TARE is safe and offers a survival benefit in naive patients, as well as in responders.

References

24

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

, , +9

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.3K citations · Full text

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet et al. · Journal of Hepatology · 2001 · 4.1K citations

, , +10

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater, Peter R. Galle, Shahid A. Khan et al. · Journal of Hepatology · 2014 · 1.5K citations

Hepatogastroenterology

Guanlin Liang, Tianfu Wen, Kai Mi et al. · Hepatogastroenterology · 2011 · 686 citations